Key facts
- Notable investors include Plug and Play Tech Center, BSV Ventures, Rubik HUB.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Misslaboratory
- ·The full record, as it builds
Funding rounds
No funding rounds for Misslaboratory are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Misslaboratory
Developer of a clinical hormone-testing platform designed to advance quantitative hormone measurement for fertility, endocrinology, and therapeutic management. The company's platform uses portable electrochemical sensor strips, a handheld reader, and a secure data dashboard to deliver fast, quantitative hormone readings from minimal sample volumes, enabling clinicians, researchers, and healthcare providers to conduct frequent monitoring with actionable data that supports personalized care, optimized treatment adjustments, and enhanced clinical insights. .
- Sector
- Healthcare
- HQ
- Vilnius, Lithuania
- Founded
- 2025
- Employees
- 2
- Website
- misslaboratory.com/
- Ownership
- Privately Held (backing)
Misslaboratory doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Misslaboratory shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Misslaboratory in its N-PORT filings yet. We sweep new filings monthly.